Analysis of clinically-reported, memantine-induced cardiovascular adverse responses using the halothane-anesthetized dogs: Reverse translational study
Open Access
- 23 January 2022
- journal article
- research article
- Published by Elsevier in Journal of Pharmacological Sciences
- Vol. 148 (4) , 343-350
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development (JP21mk0101189)
- Japan Society for the Promotion of Science (19K16505, 20K16136)
This publication has 27 references indexed in Scilit:
- Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for PsychopharmacologyJournal of Psychopharmacology, 2010
- A review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitorsInternational Journal of Geriatric Psychiatry, 2010
- MemantineCNS Drugs, 2009
- Sensitive and reliable proarrhythmiain vivoanimal models for predicting drug‐induced torsades de pointes in patients with remodelled heartsBritish Journal of Pharmacology, 2008
- Does memantine induce bradycardia? A study in the French PharmacoVigilance DatabasePharmacoepidemiology and Drug Safety, 2008
- Memantine agonist action at dopamine D2High receptorsSynapse, 2007
- The chemical biology of clinically tolerated NMDA receptor antagonistsJournal of Neurochemistry, 2006
- Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving DonepezilJAMA, 2004
- Effects of a Typical IKr Channel Blocker Sematilide on the Relationship Between Ventricular Repolarization, Refractoriness and Onset of Torsades de PointesThe Japanese Journal of Pharmacology, 2002
- An improved method to correct the QT interval of the electrocardiogram for changes in heart rateJournal of Pharmacological Methods, 1989